- Home
- ONEW vs ENGN Comparison
ONEW vs ENGN Comparison
Compare ONEW & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONEW
- ENGN
- Stock Information
- Founded
- ONEW 2014
- ENGN 1999
- Country
- ONEW United States
- ENGN Canada
- Employees
- ONEW N/A
- ENGN N/A
- Industry
- ONEW Auto & Home Supply Stores
- ENGN
- Sector
- ONEW Consumer Discretionary
- ENGN
- Exchange
- ONEW Nasdaq
- ENGN Nasdaq
- Market Cap
- ONEW 318.6M
- ENGN 297.7M
- IPO Year
- ONEW 2020
- ENGN N/A
- Fundamental
- Price
- ONEW $17.62
- ENGN $5.40
- Analyst Decision
- ONEW Buy
- ENGN Buy
- Analyst Count
- ONEW 5
- ENGN 9
- Target Price
- ONEW $23.75
- ENGN $25.22
- AVG Volume (30 Days)
- ONEW 137.1K
- ENGN 36.4K
- Earning Date
- ONEW 05-01-2025
- ENGN 03-10-2025
- Dividend Yield
- ONEW N/A
- ENGN N/A
- EPS Growth
- ONEW N/A
- ENGN N/A
- EPS
- ONEW N/A
- ENGN N/A
- Revenue
- ONEW $1,784,431,000.00
- ENGN N/A
- Revenue This Year
- ONEW $5.21
- ENGN N/A
- Revenue Next Year
- ONEW $4.08
- ENGN N/A
- P/E Ratio
- ONEW N/A
- ENGN N/A
- Revenue Growth
- ONEW N/A
- ENGN N/A
- 52 Week Low
- ONEW $14.13
- ENGN $4.42
- 52 Week High
- ONEW $31.36
- ENGN $18.40
- Technical
- Relative Strength Index (RSI)
- ONEW 51.15
- ENGN 42.54
- Support Level
- ONEW $15.96
- ENGN $4.90
- Resistance Level
- ONEW $16.97
- ENGN $5.60
- Average True Range (ATR)
- ONEW 1.12
- ENGN 0.52
- MACD
- ONEW 0.04
- ENGN 0.02
- Stochastic Oscillator
- ONEW 91.54
- ENGN 45.93
About ONEW OneWater Marine Inc.
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segment- Dealerships and Distribution. Its dealer groups are located throughout the Southeast, Gulf Coast, Mid-Atlantic, and Northeast. The company's revenue profile is comprised of new boat sales, pre-owned boat sales, finance and insurance products, repair and maintenance services, and parts and accessories. Majority of revenue is generated from sale of new boats.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.